|Articles|January 15, 2003

BioPharm International

  • BioPharm International-01-01-2003
  • Volume 16
  • Issue 1

Market Views: A Rocky Road for Generics

by Kevin Robinson For "me too" manufacturers, the growth opportunity is in Europe ? and in biogenerics.
To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

over 22 years ago

Virus Inactivation in the 1990s and into the 21st Century: Part 4, Culture Media, Biotechnology Products, and Vaccines

over 22 years ago

Biotech World: Canada's Supreme Court says "No" to Harvard Mouse

over 22 years ago

Rethinking the Economics of Chromatography: New Technologies and Hidden Costs

over 22 years ago

Outsourcing Outlook: Using Virtual Private Networks to Gain Competitive Advantage

over 22 years ago

Inside Washington: Coverage and Consolidation ? Key Issues for Biotech Companies

over 22 years ago

Employing Near-Infrared Spectroscopic Methods of Analysis for Fermentation Monitoring and Control: Part 2, Implementation Strategies

over 22 years ago

Guest Editorial: At the Governance Crossroad

over 22 years ago

Reducing Costs by Facility Design

over 22 years ago

Guidelines for Optimization and Scale-Up in Preparative Chromatography

over 22 years ago

Analytical Advances: Funneling a Flood Tide of Data ? New Software Accelerates Bioinformatic Analyses

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Contact Info

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us